Cutting Edge: Steroid Responsiveness in Foxp3+ Regulatory T Cells Determines Steroid Sensitivity during Allergic Airway Inflammation in Mice
- 1 August 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 207 (3) , 765-770
Abstract
Glucocorticoids are a highly effective first-line treatment option for many inflammatory diseases, including asthma. Some patients develop a steroid-resistant condition, yet, the cellular and molecular mechanisms underlying steroid resistance remain largely unknown. In this study, we used a murine model of steroid-resistant airway inflammation and report that combining systemic dexamethasone and intranasal IL-27 is able to reverse the inflammation. Foxp3+ regulatory T cells (Tregs) were required during dexamethasone/IL-27 treatment of steroid-resistant allergic inflammation, and importantly, direct stimulation of Tregs via glucocorticoid or IL-27 receptors was essential. Mechanistically, IL-27 stimulation in Tregs enhanced expression of the agonistic glucocorticoid receptor-α isoform. Overexpression of inhibitory glucocorticoid receptor-β isoform in Tregs alone was sufficient to elicit steroid resistance in a steroid-sensitive allergic inflammation model. Taken together, our results demonstrate for the first time, to our knowledge, that Tregs are instrumental during steroid resistance and that manipulating steroid responsiveness in Tregs may represent a novel strategy to treat steroid refractory asthma. Key Points Supplementing IL-27 during Dex treatment attenuates steroid-resistant inflammation. IL-27 and Dex directly act on Tregs to reverse steroid-resistant inflammation. IL-27 upregulates agonistic glucocorticoid receptor expression in Tregs.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI125247)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI147498)
- HHS | NIH | National Heart, Lung, and Blood Institute (HL103453)
- HHS | NIH | National Heart, Lung, and Blood Institute (HL081064)
- HHS | NIH | National Heart, Lung, and Blood Institute (HL60917)
- HHS | NIH | National Heart, Lung, and Blood Institute (HL109250)
- American Asthma Foundation
This publication has 20 references indexed in Scilit:
- Corticosteroids in the treatment of acute asthmaAnnals of Thoracic Medicine, 2014
- Glucocorticoid Receptor-Beta Up-Regulation and Steroid Resistance Induction by IL-17 and IL-23 Cytokine Stimulation in Peripheral Mononuclear CellsJournal of Clinical Immunology, 2012
- Inflammatory signatures for eosinophilic vs. neutrophilic allergic pulmonary inflammation reveal critical regulatory checkpointsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Discovery of Glucocorticoid Receptor-β in Mice with a Role in MetabolismMolecular Endocrinology, 2010
- Human glucocorticoid receptor isoform β: recent understanding of its potential implications in physiology and pathophysiologyCellular and Molecular Life Sciences, 2009
- Glucocorticoid resistance in inflammatory diseasesThe Lancet, 2009
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in MiceThe Journal of Immunology, 2008
- Glucocorticoid receptor isoforms generate transcription specificityTrends in Cell Biology, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006